Acknowledgements & Conclusion

Acknowledgments

We would like to sincerely thank the following groups and individuals for their generous support throughout our project:

• Maxwell Lab and Davidson Lab – for providing access to lab space and the invaluable support of their graduate students.
• The Kim Lab – for the guidance and assistance offered by their graduate students.
• BioZone and the Institute of Biomedical Engineering – for access to their laboratory facilities and technical support.
• University of Toronto Engineering Society – for their continued support and resources that helped sustain our work.

Each of these partners have all been instrumental in transforming Mystiphage from an idea into a tangible force for scientific and societal progress, paving the way for a new era of precision biologics and global antimicrobial resilience.

Conclusion

Looking ahead, Mystiphage aims to redefine the standard of care in phage therapy, delivering faster and more accessible treatments for those battling resistant infections. By uniting breakthrough science, ethical innovation, and strategic execution, we are paving the way for phage therapeutics to become a cornerstone of modern medicine. Our mission is clear: we are dedicated to building a future where every patient facing a multidrug-resistant infection can benefit from the precision and promise of Mystiphage.